Oral anticoagulants in patients with coronary artery disease: An inexpensive and effective strategy

Thrombosis Research

Volumn 109, Issue 4, 2003, Pages 159-161

  Anand, Sonia S ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; THROMBIN INHIBITOR;

ACUTE HEART INFARCTION; ANTICOAGULANT THERAPY; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; INTERNATIONAL STANDARD UNIT; MEDICAL DECISION MAKING; MEDICAL LITERATURE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0038174977     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00180-4     Document Type: Editorial

References (28)

1. International Anticoagulation Review Group Collaborative analysis of long-term anticoagulant administration after acute myocardial infarction. Lancet. 7640:1970;203-209.
2. Chalmers T.C., Matta R.J., Smith H., Kunzler A.M. Evidence favouring the use of anticoagulants in the hospital phase of acute myocardial infarction. N. Engl. J. Med. 297:1977;1091-1096.
3. Anand S., Yusuf S. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. JAMA. 282(21):1999 (Dec. 1);2058-2067.
4. Borchgrevink C.F. Long-term anticoagulant therapy in angina pectoris and myocardial infarction. Acta med. scand. supplementum. 1960;359 Oslo Univ. Press.
5. Harvald B., Hilden T., Letman H., Lund E., Thaysen E.H., Worning H. Long-term anti-coagulant treatment in myocardial infarction. Acta Med. Scand. 21:1961;983-987.
6. Apenstrom G., Korsan-Bengtsen K. A double blind study of dicumarol prophylaxis in coronary heart disease. Acta Med. Scand. 176:1964;563-575.
7. Conrad L.L., Kyriacopoulos J.D., Wiggins C.W., Honick G.L. Prevention of recurrences of myocardial infarction. Arch. Intern. Med. 114:1964;348-358.
8. Loeliger E.A., Hensen A., Kroes F.et al. A double-blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med. Scand. 182:1967;549-566.
9. Lovell R.R., Denborough M.A., Nestel P.J., Goble A.J. A controlled trial of long-term treatment with anticoagulants after myocardial infarction in 412 male patients. Med. J. Aust. 2:1967;97-104.
10. Seaman A.J., Griswold H.E., Reaume R.B., Ritzmann L. Long-term anticoagulant prophylaxis after myocardial infarction; final report. N. Engl. J. Med. 281:1969;115-119.
11. Sorensen H.O., Friis T., Jorgensen A.W., Jorgensen M.B., Nissen N.I. Anticoagulant treatment of acute coronary thrombosis. Acta Med. Scand. 185:1969;65-72.
12. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction stroke in high risk patients. BMJ. 324(7329):2002 (Jan. 12);71-86.
13. Sixty Plus Reinfarction Study Research Group A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet. ii:1980;989-994.
14. Smith P., Arnesen H., Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N. Engl. J. Med. 323:1990;147-152.
15. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet. 343:1994;499-503.
16. Coumadin Aspirin Reinfarction Study (CARS) Investigators Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Lancet. 350:1997;389-396.
17. Post Coronary Artery Bypass Graft Trial Investigators The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low dose anticoagulation on obstructive changes in saphenous vein coronary artery bypass grafts. N. Engl. J. Med. 336:1997;153-162.
18. Anand S.S.et al. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction. Circulation. 98:1998;1064-1070.
19. van Es R.F., Jonker J.J., Verheugt F.W., Deckers J.W., Grobbee D.E. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet. 360(9327):2002;109-113.
20. Hurlen M., Abdelnoor M., Smith P., Erikssen J., Arnesen H. Warfarin, aspirin, or both after myocardial infarction. N. Engl. J. Med. 347(13):2002;969-974.
21. The OASIS Investigators Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. J. Am. Coll. Cardiol. 37:2001;475-485.
22. Fiore L.D., Ezekowitz M.D., Brophy M.T., Lu D., Sacco J., Peduzzi P. Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study. Circulation. 105:2002;557-563.
23. Huynh T., Theroux P., Bogaty P., Nasmith J., Solymoss S. Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery. Circulation. 103:2001;3069-3074.
24. Ten Berg J.M., Kelder J.C., Suttorp M.J., Mast E.G., Bal E., Ernst S.M.et al. Effect of coumarins started before coronary angioplasty on acute complications and long-term follow-up: a randomized trial. Circulation. 102:2000;386-391.
25. Anand S., Yusuf S. Oral anticoagulants in patients with coronary artery disease. J. Am. Coll. Cardiol. 41:2003;62S-69S.
26. Hirsh J., Dalen J., Anderson D., Poller L., Bussey H., Ansell J.et al. Oral anticoagulants - mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 119(1):2001;8S-21S.
27. The CURE Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med. 345(7):2001;494-502.
28. Francis C.W., Davidson B.L., Berkowitz S.D., Lotke P.A., Ginsberg J.S., Lieberman J.R.et al. Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial. Ann. Intern. Med. 137(8):2002;648-655.